Ocata Therapeutics Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 65

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 11

  • Investments
  • 2

Ocata Therapeutics General Information

Description

Provider of cellular therapies and regenerative medicine. The company provides stem cell-based technologies and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies. It also provides regenerative medicine or regenerating human of cells.

Contact Information

Website
www.ocata.com
Formerly Known As
Advanced Cell Technology, A.C.T. Holdings, Inc., Advanced Cell Technology, Inc., Two Moons Kachinas Corp, C T Holdings Inc, A.C.T Holdings, Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 33 Locke Drive
  • Marlborough, MA 01752
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 33 Locke Drive
  • Marlborough, MA 01752
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocata Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ocata Therapeutics‘s full profile, request access.

Request a free trial

Ocata Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of cellular therapies and regenerative medicine. The company provides stem cell-based technologies and other pr
Drug Discovery
Marlborough, MA
65 As of 2016

South San Francisco, CA
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ocata Therapeutics Competitors (103)

One of Ocata Therapeutics’s 103 competitors is Maze Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Maze Therapeutics Formerly VC-backed South San Francisco, CA
Humacyte Formerly VC-backed Durham, NC
Orgenesis Corporation Germantown, MD
Gradalis Private Equity-Backed Carrollton, TX
etherna Formerly VC-backed Niel, Belgium
You’re viewing 5 of 103 competitors. Get the full list »

Ocata Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ocata Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ocata Therapeutics‘s full profile, request access.

Request a free trial

Ocata Therapeutics Acquisitions (2)

Ocata Therapeutics’s most recent deal was a Merger/Acquisition with Mytogen for . The deal was made on 20-Sep-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mytogen 20-Sep-2007 Merger/Acquisition Other Healthcare Services
Infigen 08-Feb-2007 Merger/Acquisition Biotechnology
To view Ocata Therapeutics’s complete acquisitions history, request access »

Ocata Therapeutics FAQs

  • When was Ocata Therapeutics founded?

    Ocata Therapeutics was founded in 1994.

  • Where is Ocata Therapeutics headquartered?

    Ocata Therapeutics is headquartered in Marlborough, MA.

  • What is the size of Ocata Therapeutics?

    Ocata Therapeutics has 65 total employees.

  • What industry is Ocata Therapeutics in?

    Ocata Therapeutics’s primary industry is Drug Discovery.

  • Is Ocata Therapeutics a private or public company?

    Ocata Therapeutics is a Private company.

  • What is the current valuation of Ocata Therapeutics?

    The current valuation of Ocata Therapeutics is .

  • What is Ocata Therapeutics’s current revenue?

    The current revenue for Ocata Therapeutics is .

  • How much funding has Ocata Therapeutics raised over time?

    Ocata Therapeutics has raised $106M.

  • Who are Ocata Therapeutics’s investors?

    Alpha Capital Partners, Anthem Venture Partners, Brio Capital, Bushido Capital Partners, and Cranshire Capital Advisors are 5 of 19 investors who have invested in Ocata Therapeutics.

  • Who are Ocata Therapeutics’s competitors?

    Maze Therapeutics, Humacyte, Orgenesis, Gradalis, and etherna are some of the 103 competitors of Ocata Therapeutics.

  • When was Ocata Therapeutics acquired?

    Ocata Therapeutics was acquired on 10-Feb-2016.

  • Who acquired Ocata Therapeutics?

    Ocata Therapeutics was acquired by Astellas Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process